AZD3463 ALK/IGF1R Inhibitor: Advanced Workflows in Neuroblas
2026-05-13
AZD3463 empowers researchers to dissect ALK-driven pathways and overcome resistance in neuroblastoma models. Learn how to optimize protocols, implement combination strategies, and troubleshoot common pitfalls for reproducible, translational results.
MRT68921 ULK1 Kinase Inhibitor: Precision Autophagy Dissecti
2026-05-12
MRT68921 empowers researchers with nanomolar-selective, dual ULK1/2 inhibition for robust autophagy pathway interrogation. With validated readouts and actionable troubleshooting, it stands out as a high-fidelity tool for dissecting cellular recycling and lipid metabolism models.
Dual-Action p38α MAPK Inhibitors Promote Dephosphorylation
2026-05-12
The referenced study uncovers how certain p38α MAPK inhibitors not only block kinase activity but also accelerate dephosphorylation by stabilizing a kinase conformation that exposes the phospho-threonine to phosphatases. This dual-action mechanism suggests new avenues for designing kinase inhibitors with enhanced potency and specificity, offering direct implications for inflammation and cancer research models.
Lycopene Mitigates DON-Induced Intestinal Damage via ERK Pat
2026-05-11
This study demonstrates that lycopene protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and NLRP3 inflammasome activation by targeting the ERK signaling pathway. The findings provide mechanistic insight into lycopene's anti-inflammatory and barrier-preserving effects, with implications for mitigating mycotoxin-related gut damage.
Nitric Oxide-Driven Nanomotors Enhance Immunotherapy for Gli
2026-05-11
This study introduces a chemotactic nanomotor system that uses nitric oxide signaling to precisely target glioblastoma, overcoming blood-brain barrier challenges and enhancing immune-mediated tumor clearance. The approach integrates selective tumor microenvironment response with multi-step immune activation, presenting a significant advance in brain tumor immunotherapy.
GSH and GSSG Assay Kit: Precision Reduced Glutathione Detect
2026-05-10
Unlock robust, quantitative redox state analysis with the GSH and GSSG Assay Kit. This platform delivers sensitive, reproducible results for oxidative stress research across complex biological samples, empowering translational discoveries in cancer, immunometabolism, and redox biology.
Optimized hiPSC Platelet Protocol: Efficiency and Cost Reduc
2026-05-09
This study presents a systematically optimized protocol for deriving functional platelets from human induced pluripotent stem cells, addressing bottlenecks in yield, cost, and efficiency. Through strategic culture refinements and small molecule supplementation, the protocol shortens differentiation time and enhances output, with significant implications for regenerative medicine and cell therapy.
Wortmannin: Strategic PI3K Inhibition for Translational Prog
2026-05-09
This thought-leadership article explores the mechanistic foundations and translational opportunities of Wortmannin—a benchmark PI3K inhibitor—in the study of cancer resistance, ferroptosis, and advanced disease models. Integrating mechanistic evidence, workflow guidance, and strategic foresight, it empowers researchers to harness irreversible PI3K inhibition for actionable translational advances, with direct reference to recent discoveries in hepatocellular carcinoma and a practical protocol section.
Ziprasidone Inhibits GOT1: Redox and Metabolic Disruption in
2026-05-08
Yang et al. (2022) demonstrate that ziprasidone acts as a non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox homeostasis in pancreatic ductal adenocarcinoma (PDAC) cells. This mechanistic insight identifies GOT1 as a promising therapeutic target and reveals new vulnerabilities in PDAC metabolic regulation.
BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma RGC Models
2026-05-07
The referenced study demonstrates that BMP4-GPX4 signaling reduces ferroptosis and enhances the differentiation of retinal stem cells (RSCs) into retinal ganglion cells (RGCs) in a mouse glaucoma model. These findings highlight a potential therapeutic avenue for protecting RGCs and improving outcomes after stem cell transplantation in glaucoma characterized by high intraocular pressure.
BFH772 (VEGFR2 inhibitor): Technical Use and Workflow Guidan
2026-05-07
BFH772 is a highly selective VEGFR2 inhibitor designed for precise inhibition of VEGFR2-mediated angiogenesis, particularly in tumor research models. It is unsuitable for protocols requiring water solubility or broad-spectrum kinase inhibition but is optimal where selectivity and organic solvent compatibility are critical.
Celastrol-Induced Mitochondrial Cholesterol Metabolism in Li
2026-05-06
This study uncovers how celastrol disrupts mitochondrial cholesterol homeostasis via the CAV-1/SCP2 axis, leading to mitophagy and suppression of liver cancer growth. The mechanistic insights highlight organelle-specific cholesterol metabolism as a promising therapeutic target and provide a foundation for future translational strategies.
Reliable Assay Results with HyperFluor™ 488 Goat Anti-Mouse
2026-05-06
This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays, illustrating how HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody (SKU K1204) enhances detection sensitivity and reproducibility. With evidence-backed optimization and practical protocol guidance, researchers can confidently improve immunofluorescence, flow cytometry, and western blot workflows using this fluorescently labeled secondary antibody.
Transmission Dynamics of Carbapenemase Genes in CREC During
2026-05-05
This study provides a detailed molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. By dissecting carbapenemase-encoding gene (CEG) localization, plasmid transfer, and resistance phenotypes, it offers new insight into the mechanisms and risk factors driving multidrug resistance.
Iron Homeostasis Modulates Nanoplastic-Induced Lung Fibrosis
2026-05-05
This study uncovers how polystyrene nanoplastics (PS-NPs) drive pulmonary fibroblast proliferation and activation through dysregulated iron ion accumulation, elucidating the intercellular crosstalk that underpins lung fibrosis. Targeting iron homeostasis and cellular interactions emerges as a promising therapeutic avenue for PS-NPs-induced pulmonary pathology.
461 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page